Hounchell, Julie, A

Prime Medicine is a biotechnology company focused on transforming the lives of patients with debilitating diseases through its innovative Prime Editing platform. This next-generation gene editing technology aims to address the genetic causes of diseases by enabling precise and efficient editing of DNA at specific locations in the genome, potentially offering long-lasting cures. With broad applications, Prime Editing is designed to target approximately 90% of known disease-causing mutations across various organisms, organs, and cell types. The company's vision is to revolutionize disease treatment and enhance patient outcomes by minimizing unwanted DNA modifications while delivering impactful therapeutic solutions. Generated from the website